SecBot SecBot

TOMZ

TOMI Environmental Solutions, Inc.
Nasdaq· Industrial Organic Chemicals· Inc. FL· CIK 0000314227 Biotech & Drug Discovery
$1.43 −0.03 (−2.05%)
Oct 26 4:00 PM ET · prev $1.46
Market cap
$14.1M
Nano cap
Consensus
Buy
86% Buy or better · 7 analysts
Median target
$7.00
+390% · range $7.00–7.00
Next earnings
Nov 6
in 10 days · EPS est. $0.00
1 year
−48.2%
from $2.76 · Oct 27
30 days
+5.1%
from $1.36
52-week range
$1.27–3.24
−56% from high · low Sep 30
Avg volume 20D
31.8K
Oct 5 spike 102.5K
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
18
analyzed by SecBot
SecBot read BULLISH 9 reports · 90 days
Balance 0 bearish · 3 bullish · 2 mixed · 4 neutral oldest → newest, height = score
Avg score ·High conf. 5/9 ·Next Earnings date, Nov 6, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 3 added (0 new), 1 trimmed or exited.

  • AnalystsBULLISH

    6 of 7 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.120 → $0.000 over 90 days. 1 up, 0 down in 30 days.

  • TrendDOWNTREND

    9% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD FIDUCIARY TRUST COADD74,433$61.3K
NORTHERN TRUST CORPADD22,117$18.2K
CITIGROUP INCDOUBLED14,866$12.2K
UBS Group AGTRIM2,500$2.1K
UBS Group AGADD4,062$2.2K
CITIGROUP INCNEAR_EXIT16$9.00
RENAISSANCE TECHNOLOGIES LLCTRIM22,700$17.7K
CITIGROUP INCDOUBLED923$720.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

7 analysts
Buy 86% rate it Buy or better
Strong Buy2Buy4Hold1Sell0Strong Sell0
12-month targets · 1 analysts

Price is below the lowest target. Median implies +390%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Jul 30, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Apr 22, 2026
PAUL HAROLD
Director
AWARD$5.5K
Apr 22, 2026
Fragasso Francesco
Director
AWARD$5.5K
Apr 22, 2026
Lim Boh Soon
Director
AWARD$5.5K

Earnings setup

Estimates
Nov 6
reports in 10 days
$0.00
EPS estimate, this quarter
+100%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.00$0.00–$0.00+100.0%$3.0M
Next Q$0.09$0.09–$0.09+200.0%$5.0M
Current FY-$0.07-$0.07–-$0.07+84.4%$11.9M
Next FY$0.12$0.12–$0.12+0.0%$18.2M
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Jul 17, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.

SecBot reports

18 filings · 8 press releases · 4 bullish · 4 bearish · 3 mixed · 7 neutral
All TOMZ filing & press-release reports (26)